Scavenger receptor BI - A cell surface receptor for high density lipoprotein

Current Opinion in Lipidology

Volumn 8, Issue 3, 1997, Pages 181-188

  Rigotti, Attilio ^a   Trigatti, Bernardo ^a   Babitt, Jodie ^a   Penman, Marsha ^a   Xu, Shanghze ^a   Krieger, Monty ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; CHOLESTEROL; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTOR; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; VITELLOGENIN;

AMINO ACID SEQUENCE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL METABOLISM; CHOLESTEROL TRANSPORT; HUMAN; LIPID TRANSPORT; LIPOPROTEIN METABOLISM; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; RECEPTOR BINDING; REVIEW;

ANIMALS; ANTIGENS, CD36; CLONING, MOLECULAR; HUMANS; LIPOPROTEINS, HDL; MEMBRANE PROTEINS; ORGAN SPECIFICITY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, LIPOPROTEIN; RECEPTORS, SCAVENGER; RECOMBINANT PROTEINS; SCAVENGER RECEPTORS, CLASS B;

EID: 0030759445     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199706000-00009     Document Type: Review

References (113)

1. Kannel BW, Castelli WP, Gordon T, McNamara PM: Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med 1971, 74:1-12.
2. Gordon DJ, Rifkind BM: High density lipoprotein. The clinical implications of recent studies. N Engl J Med 1989, 321:1311-1316.
3. Brown MS, Goldstein JL: A receptor-mediated pathway for cholesterol homeostasis. Science 1986, 232:34-47.
4. Eisenberg S: High density lipoprotein metabolism. J Lipid Res 1984, 25:1017-1058.
5. Fielding CJ, Fielding PE: Molecular physiology of reverse cholesterol transport. J Lipid Res 1995, 36:211-228.
6. Johnson WJ, Mahlberg FH, Rothblat GH, Phillips MC: Cholesterol transport between cells and high density lipoproteins. Biochim Biophys Acta 1991, 1085:273-298.
7. Oram JF, Yokoyama S: Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996, 37:2473-2491. This recent review considers the pathways for cholesterol and phospholipid efflux from cells, with an emphasis on HDL apolipoprotein-mediated efflux. For another view of lipid removal from cells see [6].
8. Breslow JL. Familial disorders of high density lipoprotein metabolism. In The metabolic and molecular bases of inherited diseases. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 1995:2031-2052.
9. Rader DJ, Ikewaki K: Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr Opin Lipidol 1996, 7:117-123.
10. Goldberg IJ, Blaner WS, Vanni TM, Moukides M, Ramakrishnan R: Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. J Clin Invest 1990, 86:463-473.
11. Horowitz BS, Goldberg IJ, Merab J, Vanni TM, Ramakrishnan R, Ginsberg HN: Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest 1993, 91:1743-1752.
12. Glomset JA: The plasma lecithin : cholesterol acyltransferase reaction. J Lipid Res 1968, 9:155-167.
13. Tall AR: Plasma cholesteryl ester transfer protein. J Lipid Res 1993, 34:1255-1274.
14. Gwynne JT, Strauss JF: The role of lipoproteins in steroidogenesis and cholesterol metabolism in steroidogenic glands. Endocr Rev 1982, 3:299-329.
15. Botham KM, Bravo E: The role of lipoprotein cholesterol in biliary steroid secretion. Studies with In vivo experimental models. Prog Lipid Res 1995, 34:71-97.
16. Gwynne JT, Hess B: The role of high density lipoproteins in rat adrenal cholesterol metabolism and steroidogenesis. J Biol Chem 1980, 255:10875-10883.
17. Stein Y, Dabach Y, Hollander G, Halperin G, Stein O: Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim Biophys Acta 1983, 752:98-105.
18. Glass C, Pittman RC, Weinstein DW, Steinberg D: Dissociation of tissue uptake of cholesterol from that of apoprotein A-I of rat high density lipoproteins: selective delivery of cholesterol to liver, adrenal and gonad. Proc Natl Acad Sci U S A 1983, 80:5435-5439.
19. Leitersdorf E, Stein O, Eisenberg S, Stein Y: Uptake of rat plasma HDL subfractions labeled with [3H]cholesteryl linoleyl ether or with 1251 by cultured hepatocytes and adrenal cells. Biochim Biophys Acta 1984, 796:72-82.
20. Reaven E, Chen YI, Spicher M, Azhar S: Morphological evidence that high density lipoproteins are not internalized by steroid producing cells during in situ organ perfusion. J Clin Invest 1984, 74:1384-1397.
21. Glass C, Pittman RC, Given M, Steinberg D: Uptake of high density lipoprotein-associated apoprotein A-I and cholesteryl esters by 16 tissues of the rat in vivo and by adrenal glands and hepatocytes in vitro. J Biol Chem 1985, 260:744-750.
22. Leitersdorf E, Israeli A, Stein O, Eisenberg S, Stein Y: The role of apolipoproteins of HDL in the selective uptake of cholesteryl linoleyl ether by cultured rat and bovine adrenal cells. Biochim Biophys Acta-1986, 878:320-329.
23. MacKinnon M, Savage J, Wishart R, Barter P: Metabolism of high density lipoproteins by the perfused rabbit liver. J Biol Chem 1986. 261:2548-2552.
24. Reaven E, Chen YD, Spicher M, Hwang SF, Mondon CE, Azhar S: Uptake of low density lipoproteins by rat tissues: special emphasis on the luteinized ovary. J Clin Invest 1986, 77:1971-1984.
25. Pittman RC, Knecht TP, Rosenbaum MS, Taylor CA: A nonendocytic mechanism for the selective uptake of high density lipoprotein-associated cholesterol esters. J Biol Chem 1987, 262:2443-2450.
26. Arbeeny CM, Rifici VA, Eder HA: The uptake of the apoprotein and cholesteryl ester of high density lipoproteins by perfused rat liver. Biochim Biophys Acta 1987, 917:9-17.
27. Reaven E, Boyles J, Spicher M, Azhar S: Evidence for surface entrapment of cholesterol-rich lipoproteins in the luteinized ovary. Arteriosclerosis 1988, 8:298-309.
28. Gwynne JT, Mahafee DD: Rat adrenal uptake and metabolism of high density lipoprotein cholesteryl ester. J Biol Chem 1989, 264:8141-8150.
29. Azhar S, Stewart D, Reaven E: Utilization of cholesterol-rich lipoproteins by perfused rat adrenals. J Lipid Res 1989, 30:1799-1810.
30. Wishart R, MacKinon M: Uptake and metabolism of high density lipoproteins by cultured rabbit hepatocytes. Biochim Biophys Acta 1990, 1044:375-381.
31. Fong BS, Angel A: Transfer of free and esterified cholesterol from low density lipoproteins and high density lipoproteins to human adipocytes. Biochim Biophys Acta 1989, 1004:53-60.
32. DeLamatre JG, Carter RM, Hornich CA: Evidence for extralysosomal hydrolysis of high density lipoprotein cholesteryl esters in rat hepatoma (Fu5AH): a model for delivery of high density lipoprotein cholesterol. J Cell Physiol 1991, 146:18-24.
33. Goldberg DI, Beltz WF, Pittman RC: Evaluation for the cellular uptake of high density lipoprotein cholesterol esters in rabbits. J Clin Invest 1991, 87:331-346.
34. Rinninger F, Brundert M, Jackle S, Galle PR, Busch C, Izbicki JR, Rogiers X, Henne-Bruns D, Kremer B, Broelsch CE, Greten H: Selective uptake of high density lipoprotein-associated cholesteryl esters by human hepatocytes in primary culture. Hepatology 1994, 19:1100-1114.
35. Pieters MN, Schouten D, VanBerkel TJC: In vitro and in vivo evidence for the role of HDL in reverse cholesterol transport. Biochim Biophys Acta 1994, 1225:125-134.
36. Turley SD, Dietschy JM: The metabolism and excretion of cholesterol by the liver. In The liver: biology pathobiology. Edited by Arias IM, Jakoby WB, Popper H, Schachter D, Schafritz DA. New York: Raven Press: 1988:617-641.
37. Assman G, von Eckardstein A, Brewer HB: Familial high density lipoprotein deficiency: Tangier disease. In The metabolic and molecular bases of inherited disease. Edited by Scriver CR, Beaudet AL, Sly WS, Valle D. New York: McGraw-Hill; 1995:2053-2072.
38. McKnight GL, Reasoner J, Gilbert T, Sundquist KO, Hokland BM, McKernan PA, Champagne J, Johnson CJ, Bailey MC, Holly R et al.: Cloning and expression of a cellular high density lipoprotein-binding protein that is up-regulated by cholesterol loading. J Biol Chem 1992, 267:12131-12141.
39. Brissette L, Falstrault L: Analysis of the selective uptake of the cholesteryl ester of human intermediate density lipoproteins by HepG2 cells. Biochim Biophys Acta 1994, 1213:5-13.
40. Brissette L, Falstrault L, Lafond L, Izem L: The selective uptake of the cholesteryl esters of low density lipoproteins parallels the activity of protein kinase C. Biochim Biophys Acta 1996, 1301:133-140.
41. Acton S, Rigotti A, Landschulz K, Xu S, Hobbs HH, Krieger M: Identification of scavenger receptor SR-B1 as a high density lipoprotein receptor. Science 1996, 271:518-520. In this study SR-B1 was shown to be the first molecularly well defined cell surface HDL receptor that mediates selective lipid uptake. SR-B1 was shown to bind HDL with high affinity, be expressed primarily in the liver and steroidogenic tissues, and mediate selective cholesterol uptake from HDL to cells via a mechanism distinct from the classic LDL receptor pathway.
42. Krieger M, Acton S, Ashkenas J, Pearson A, Penman M, Resnick D: Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem 1993, 268:4569-4572.
43. Krieger M, Herz J: Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu Rev Biochem 1994, 63:601-637.
44. Sparrow CP, Parthasarathy S, Steinberg D: A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein. J Biol Chem 1989, 264:2599-2604.
45. Arai H, Kita T, Yokode M, Narumiya S, Kawai C: Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins. Biochem Biophys Res Commun 1989, 159:1375-1382.
46. VanBerkel TJ, De Rijke YB, Kruijt JK: Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoprotein in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J Biol Chem 1991, 266:2282-2289.
47. Bickel PE, Freeman MW: Rabbit aortic smooth muscle cells express inducible macrophage scavenger receptor messenger RNA that is absent from endothelial cells. J Clin Invest 1992, 90:1450-1457.
48. Endenmann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA: CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem 1993, 268:11811-11816.
49. Acton SL, Scherer PE, Lodish HF, Krieger M: Expression cloning of SR-B1, a CD36-related class B scavenger receptor. J Biol Chem 1994, 269:21003-21009.
50. Pearson A, Lux A, Krieger M: Expression cloning of dSR-CI, a class C macrophage-specific scavenger receptor from Drosophila melanogaster. Proc Natl Acad Sci U S A 1995, 92:4056-4060.
51. Calvo D, Vega MA: Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 1993, 268:18929-18935.
52. Calvo D, Dopazo J, Vega MA: The CD36, CLA-1 (CD36L1), and LIMPII(CD36L2) gene family: cellular distribution, chromosomal location, and genetic evolution. Genomics 1995, 25:100-106.
53. Vega MA, Segui-Real B, Alcalde Garcia J, Cales C, Rodriguez F, Vanderkerckhove, Sandoval IV: Cloning, sequencing, and expression of a cDNA encoding rat LIMPII, a novel 74-kDa lysosomal membrane protein related to the surface adhesion protein CD36. J Biol Chem 1991, 266:16818-16824.
54. Oquendo P, Hundt E, Lawler J, Seed B: CD36 directly mediates cytoadherence of Plasmodium falciparum infected erythrocytes. Cell 1989, 58:95-101.
55. Armesilla AL, Vega MA: Structural organization of the gene for human CD36 glycoprotein. J Biol Chem 1994, 269:18985-18991.
56. Hart K, Wilcox M: A Drosophila gene encoding an epithelial membrane protein with homology to CD36/LIMPII. J Mol Biol 1993, 234:249-253.
57. Franc NC, Dimarcq J-L, Laguex M, Hoffman J, Ezekowitz RAB: Croquemort, a novel Drosophila hemocyte/macrophage receptor that recognizes apoptotic cells. Immunity 1996, 4:431-443.
58. Greenwalt DE, Lipsky RH, Ockenhouse CF, Ikeda H, Tandon NN, Jamieson GA: Membrane glycoprotein CD36: a review of its role in adherence, signal transduction, and transfusion medicine. Blood 1992, 80:1105-115.
59. Tao N, Wagner SJ, Lublin DM: CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails. J Biol Chem 1996, 271:22315-22320.
60. Pearce SF, Wu J, Silverstein RL: A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: evidence for a single transmembrane domain. Blood 1994, 84:384-389.
61. Rigotti A, Acton S, Krieger M: The class B scavenger receptors SR-B1 and CD36 are receptors for anionic phospholipids. J Biol Chem 1995, 270:16221-16224.
62. Baillie AGS, Coburn CT, Abumrad NA: Reversible binding of long chain fatty acids to purified FAT the adipose CD36 homologue. J Membr Biol 1996, 153:75-81.
63. Tandon NN, Ralisz U, Jameison GA: Identification of GPIV(CD36) as a primary receptor for platelet-collagen adhesion. J Biol Chem 1989, 264:7576-7573.
64. Asch AS, Barnwell J, Silversteni RL, Nachman RL: Isolation of the thrombospondin membrane receptor. J Clin Invest 1987, 79:1054-1061.
65. Savill J, Hogg N, Ren Y, Haslett C: Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest 1992, 90:1513-1522.
66. Ren Y, Silverstein RL, Allen J, Savill J: CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med 1995, 181:1857-1862.
67. Freeman M, Ekkel Y, Rohrer L, Penman M, Freedman NJ, Chisolm GM, Krieger M: Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein. Proc Natl Acad Sci U S A 1991, 88:4931-4935.
68. Ashkenas J, Penman M, Vasile E, Acton S, Freeman M, Krieger M: Structures and high and low affinity ligand binding of murine type I and type II macrophage scavenger receptors. J Lipid Res 1993, 34:983-1000.
69. Knecht TP, Pittman RC: A plasma membrane pool of cholesteryl esters that may mediate the selective uptake of cholesteryl esters from high density lipoproteins. Biochim Biophys Acta 1989, 1002:365-375.
70. Rinninger F, Jaeckle S, Pittman RC: A pool of reversible cell-associated cholesteryl esters involved in the selective uptake of cholesteryl esters from high density lipoproteins by HepG2 hepatoma cells. Biochim Biophys Acta 1993, 1166:275-283.
71. Reaven E, Tsai L, Azhar S: Intracellular events in the 'selective' transport of lipoprotein-derived cholesteryl esters. J Biol Chem 1996, 271:16208-16217. To study the selective uptake process, fluorescent lipids were used to trace the fate of lipids after they were transfered from HDL to the plasma membrane and to characterize the properties (e.g. sensitivity to various metabolic inhibitors) of the intracellular transport of HDL-derived lipids.
72. Raeven E, Spicher M, Azhar S: Microvillar channels: a unique plasma membrane compartment for concentrating lipoproteins on the surface of rat adrenal cortical cells. J Lipid Res 1989, 30:1551-1560.
73. Rigotti A, Edelman ER, Seifert P, Iqbal S, DeMattos RB, Temel RE, Krieger M, Williams D: Regulation by adrenocorticotropic hormone of the in vivo expression of scavenger receptor class B type I (SR-B1), a high density lipoprotein receptor, in steroidogenic cells of the murine adrenal gland. J Biol Chem 1996, 271:33545-33549. SR-B1 was shown to be specifically expressed on the surfaces of steroid-producing cells in the murine adrenal gland (cortex but not medula) and its expression in vivo was regulated by treatment with hormones (induced by ACTH and suppressed by a glucocorticoid). These results provide correlative evidence supporting the hypothesis that SR-B1 is an HDL receptor that provides HDL-cholesterol as a substrate for steroidogenesis in vivo.
74. Reaven E, Shi X-Y, Azhar S: Interaction of lipoproteins with isolated ovary plasma membranes. J Biol Chem 1990, 265:19100-19111.
75. Pittman RC, Glass CK, Atkinson D, Small DM: Synthetic high density lipoprotein particles: application to studies of the apoprotein specificity for selective uptake of cholesteryl esters. J Biol Chem 1987, 262:2435-2442.
76. Green SR, Pittman RC: Selective uptake of cholesteryl esters from low density lipoproteins in vitro and in vivo. J Lipid Res 1991, 32:667-673.
77. Rinninger F, Brundert M, Jackle S, Kaiser T, Greten H: Selective uptake of low-density lipoprotein-associated cholesteryl esters by human fibroblasts, human HepG2 hepatoma cells and J774 macrophages in culture. Biochim Biophys Acta 1995, 1255:141-153.
78. Landschulz KT, Pathak RP, Rigotti A, Krieger M, Hobbs HH: Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat. J Clin Invest 1996, 98:984-995. To examine the role of SR-B1 in vivo, its tissue- and cell type-specific expression pattern and regulation in rats was studied. High-dose estrogen treatment increased SR-B1 expression in steroidogenic cells of the adrenal gland and ovary, and reduced SR-B1 protein levels in the liver. In addition, administration of human chorionic gonadotrophin induced SR-B1 expression specifically in Leydig cells of the testes. The regulated levels of SR-B1 protein expression in the steroidogenic tissues were correlated with lipid uptake from HDL. These correlative findings suggest that SR-B1 may mediate physiologically relevant substrate cholesterol uptake from HDL for steroidogenesis in vivo.
79. Plump AS, Erickson ES, Wong W, Partin JS, Breslow JL, Williams DL: Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest 1996, 97:2660-2671. Analysis of mice with targeted mutations in apolipoprotein genes established that inactivation of the apoA-I, but not apoA-II or apoE, genes resulted in an almost complete failure to accumulate cholesteryl esters in steroidogenic cells of the adrenal gland, ovary and testis. This result illustrates the importance of apoA-I, presumably via its role in selective uptake, for cholesterol homeostasis and steroid synthesis in steroidogenic tissues.
80. Bensadoun A, Berryman DE: Genetics and molecular biology of hepatic lipase. Curr Opin Lipidol 1996, 7:77-81.
81. Bamberger M, Glick JM, Rothblat GH: Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells. J Lipid Res 1983, 24:869-876.
82. Kadowaki H, Patton G, Robins SJ: Metabolism of high density lipoprotein lipids by the rat liver: evidence for participation of hepatic lipase in the uptake of cholesteryl ester. J Lipid Res 1992, 33:1689-1698.
83. Komaromy M, Azhar S, Cooper AD: Chinese hamster ovary cells expressing a cell surface-anchored form of hepatic lipase. Characterization of low density lipoprotein and chylomicron remnant uptake and selective uptake of high density lipoprotein-cholesteryl ester. J Biol Chem 1996, 271:16906-16915. A cell surface-anchored form of hepatic lipase was expressed in transfected cells in culture. This led to an increase in both the uptake of LDL via the LDL receptor pathway and selective cholesteryl ester uptake from HDL. These findings suggest that hepatic lipase can play a role in enhancing lipid delivery from lipoprotein to cells via multiple pathways.
84. Wang N, Weng W, Breslow JL, Tall AR: Scavenger receptor BI (SR-B1) is up-regulated in adrenal gland in apolipoprotein A-I and hepatic lipase knock-out mice as a response to depletion of cholesterol stores. In vivo evidence that SR-B1 is a functional high density lipoprotein receptor under feedback control. J Biol Chem 1996, 271:21001-21004. The levels of SR-B1 mRNA in the livers and adrenal glands of a variety of mutant (knockout) mice were analyzed. The investigators report an increase in SR-B1 mRNA in the adrenal glands of apoA-I and hepatic lipase knockout mice. SR-B1 mRNA was also seen to increase in ACTH-treated cultured adrenal cells. The effects of incubating cultured cells with HDL on SR-B1 expression were also examined. These results are consistent with the model that SR-B1 is a functional and regulated HDL receptor.
85. Rinninger F, Pittman RC: Regulation of the selective uptake of high density lipoprotein-associated cholesteryl esters. J Lipid Res 1987, 28:1313-1325.
86. Chen YDI, Kraemer FB, Raeven GM: Identification of specific high density lipoprotein-binding sites in rat testis and regulation of binding by human chorionic gonadotropin. J Biol Chem 1980, 255:9162-9167.
87. Gwynne JT, Mahaffee D, Brewer HB, Ney RL: Adrenal cholesterol uptake from plasma lipoproteins: regulation by corticotropin. Proc Natl Acad Sci U S A 1976, 73:4329-4333.
88. Rainey WE, Rodgers RJ, Mason JI: The role of bovine lipoproteins in the regulation of steroidogenesis and HMGCoA reductase in bovine adrenocortical cells. Steroids 1992, 57:167-173.
89. Higashijima M, Nawata H, Kato K, Ibayashi H: Studies on lipoprotein and adrenal steroidogenesis. I. Roles of low density lipoprotein-and high density lipoprotein-cholesterol in steroid production in cultured human adrenocortical cells. Endrocrinol Jpn 1987, 34:635-645.
90. Higashijima M, Kato K, Nawata H, Ibayashi H: Studies on lipoprotein and adrenal steroidogenesis. II. Utilization of low density lipoprotein- and high density lipoprotein-cholesterol for steroid production in functioning human adrenocortical adenoma cells in culture. Endrocrinol Jpn 1987, 34:647-657.
91. Hoeg JM, Loriaux L, Gregg RE, Green WR, Brewer HBJ: Impaired adrenal reserve in the Watanabe heritable hyperlipidemic rabbit: implications for LDL-receptor function in steroidogenesis. Metab Clin Exp 1985, 34:194-197.
92. Illingworth DR, Tenney TA, Orwoll TS: Corticosteroid production in abetalipoproteinemia: evidence for an impaired response to ACTH. J Lab Clin Med 1982, 100:115-126.
93. Laue M, Hoeg JM, Barnes K, Loriaux DL, Chrousos GP: The effect of mevilonin on steroidogenesis in patients with defects in the low density lipoprotein receptor pathway. J Clin Endocrinol Metab 1987, 64:531-535.
94. Allen JM, Thompson GR, Myant NB: Normal adrenocortical response to adrenocorticotropic hormone in patients with homozygous familial hypercholesterolemia. Clin Sci 1983, 65:99-101.
95. Woollen LA: Origin of cholesterol in the fetal Golden Syrian hamster: contribution of the novo sterol synthesis and maternal-derived lipoprotein cholesterol. J Lipid Res 1996, 37:1246-1257.
96. Miller GJ, Miller NE: Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet 1974, 1:16-20.
97. Thornton JR, Heaton KW, MacFarlane DG: A relation between high density lipoprotein cholesterol and bile cholesterol saturation. BMJ 1981, 283:1352-1354.
98. Petitti DB, Friedman GD, Klatsky A: Association of a history of gallbladder disease with reduced concentration of high density lipoprotein cholesterol. N Engl J Med 1981, 304:1396-1398.
99. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL: In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci US A 1993, 90:12040-12044.
100. Hubsch AP, Casas AT, Doran JE: Protective effects of reconstituted high density lipoprotein in rabbit Gram-negative bacteremia models. J Lab Clin Med 1995, 126:548-558.
101. Ulevitch RJ, Johnston AR: The modification of biophysical and endotoxic properties of bacterial lipopolysaccharides by serum. J Clin Invest 1976, 62:1313-1324.
102. Ulevitch RJ, Johnston AR, Weinstein DB: New function of high density lipoproteins. Isolation and characterization of a bacterial lipopolysaccharide-high density lipoprotein complex formed in rabbit plasma. J Clin Invest 1981, 67:827-837.
103. Munford RS, Andersen JM, Dietschy JM: Sites of tissue binding and uptake in vivo of bacterial lipopolysaccharide-high density lipoprotein complexes. J Clin Invest 1981, 68:1503-1513.
104. Munford RS, Dietschy JM: Effects of specific antibodies, hormones and lipoproteins on bacterial lipopolysaccharides injected into the rat. J Infect Dis 1985, 152:177-184.
105. Pearson AM: Scavenger receptors in innate immunity. Curr Opin Immunol 1996, 8:20-28. This paper discusses recent developments in the scavenger receptor field, in particular the potential the role of scavenger receptors, including SH-BI, in host-defense-related processes.
106. Sibbald WJ, Short A, Cohen MP, Wilson RF: Variations in adrenocortical responsiveness during severe bacterial infections: unrecognized adrenocortical insufficiency in severe bacterial infections. Ann Surg 1977, 186:29-33.
107. Bosworth DC: Reversible adrenocortical insufficiency in fulminant meningococcemia. Arch Intern Med 1979, 139:823-824.
108. Fukasawa M, Adachi H, Hirota K, Tsujimoto M, Akai H, Inoue K: SR-B1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells. Exp Cell Res 1996, 222:246-250. This study confirmed that SR-B1 expressed in cultured cells can recognize liposomes composed of anionic phospholipids (see [51]) and suggested that it may also be able to recognize apoptotic cells a characteristic shared with CD-36 (see [65,66]).
109. Ryeom SW, Silverstein HL, Scotto A, Sparrow JR: Binding of anionic phospholipids to retinal pigment epithelium may be mediated by the scavenger receptor CD36. J Biol Chem 1996, 271:20536-20539.
110. Xu S, Laccotripe M, Huang X, Rigotti A, Zannis VI, Krieger M: The apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-B1, an HDL receptor which mediates selective lipid uptake. J Lipid Res 1997, 3. This study shows that HDL apolipoproteins (apoA-I, apoA-II, apoC-III), either as lipid free forms or incorporated into phospholipid cholesterol complexes, can all mediate binding to murine SR-B1. Thus, SR-B1 may be responsible for some of the multilipoprotein and multiapolipoprotein binding activities previously described in different cell types and tissues.
111. Babbit J, Trigatti B, Rigotti A, Smart EJ, Anderson RGW, Xu S, Krieger M: Murine SR-B1, a high density lipoprotein receptor that mediates selective lipid uptake Is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 1997, 272: 13242-13249. This paper demonstrates that murine SR-B1 is extensively N-glycosylated, containing both complex as well as hybrid and/or high mannose oligosaccharide chains. Murine SR-B1 is also fatty acylated and concentrated in caveolae, both properties shared with CD36, another class B scavenger receptor. These findings raise the possibility that caveolae may play a critical role in SR-B1 mediated lipid transfer between lipoproteins and cells.
112. Fielding PE, Fielding CJ: Plasma membrane caveolae mediate the efflux of cellular free cholesterol. Biochemistry 1995, 34:14288-14294.
113. Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M: Overexpression of the HDL receptor SR-B1 alters plasma HDL and bile cholesterol levels. Nature 1997 (in press).